Showing 41 - 50 of 580
MRNA technology has proved in the context of the COVID-19 pandemic its breakthrough value as a basis for vaccines. There has been rapid development of highly safe, effective and robust mRNA vaccines, and these can be delivered at large scale. Yet the technology is the result of a long process of...
Persistent link: https://www.econbiz.de/10013184655
Persistent link: https://www.econbiz.de/10001518601
Persistent link: https://www.econbiz.de/10001528771
Persistent link: https://www.econbiz.de/10001538231
Persistent link: https://www.econbiz.de/10001538240
Persistent link: https://www.econbiz.de/10001446914
Persistent link: https://www.econbiz.de/10001439460
Persistent link: https://www.econbiz.de/10001462396
Persistent link: https://www.econbiz.de/10001463487
Persistent link: https://www.econbiz.de/10000834806